By Counterforce Health Team in Bavencio (avelumab) —

How to Get Bavencio (Avelumab) Covered by Blue Cross Blue Shield in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Bavencio Covered in New Jersey

Bavencio (avelumab) requires prior authorization from Blue Cross Blue Shield plans in New Jersey, managed through the Carelon Oncology Program. Submit your PA request with diagnosis confirmation, prior treatment history, and dosing per FDA guidelines. If denied, you have 180 days to file internal appeals, followed by New Jersey's Independent Health Care Appeals Program (IHCAP) through Maximus Federal Services. For urgent cases, request expedited review at every stage.

First step today: Have your oncologist submit the PA through Horizon Blue Cross Blue Shield's Carelon portal with HCPCS code J9023 and complete medical records.

Table of Contents

  1. Why New Jersey State Rules Matter
  2. Blue Cross Blue Shield Coverage Requirements
  3. Prior Authorization Process Step-by-Step
  4. New Jersey Step Therapy Protections
  5. Internal Appeals Process
  6. External Review Through IHCAP
  7. Continuity of Care for Cancer Patients
  8. Common Denial Reasons and Solutions
  9. When to Escalate and Get Help
  10. FAQ

Why New Jersey State Rules Matter

New Jersey's robust insurance regulations provide significant protections for cancer patients seeking coverage for specialty drugs like Bavencio. The state's laws interact with Blue Cross Blue Shield policies to create multiple safeguards:

Key New Jersey Advantages:

  • Comprehensive external review system through IHCAP with ~50% success rate for consumers
  • New step therapy override requirements effective January 2026
  • Cancer-specific continuity of care protections lasting up to one year
  • 180-day appeal deadlines (longer than many states)
  • No-cost external reviews with binding decisions

These protections apply to fully insured Blue Cross Blue Shield plans in New Jersey, including Horizon Blue Cross Blue Shield. Self-funded employer plans follow federal ERISA rules instead.

Blue Cross Blue Shield Coverage Requirements

Formulary Status

Bavencio (avelumab) is covered on Horizon Blue Cross Blue Shield formularies for FDA-approved indications but requires prior authorization as a specialty oncology injectable. The drug appears on multiple 2025-2026 formulary lists including Classic Drug List, NetResults, and Medicare plans.

Coverage at a Glance

Requirement Details Where to Find Source
Prior Authorization Required via Carelon Oncology Program Carelon PA List Horizon BCBS
HCPCS Code J9023 FDA Orange Book FDA
Formulary Tier Specialty/Medical Benefit Member Portal Horizon BCBS
Site of Care Oncology infusion center FDA labeling FDA
Appeal Deadline 180 days from denial NJ DOBI NJ State Law

FDA-Approved Indications

  • Metastatic Merkel cell carcinoma in adults who have received prior chemotherapy
  • Locally advanced or metastatic urothelial carcinoma for maintenance treatment after platinum-based chemotherapy without disease progression

Prior Authorization Process Step-by-Step

Step 1: Verify Coverage and Requirements

Call the number on your Blue Cross Blue Shield member ID card to confirm:

  • Your specific plan's formulary status for Bavencio
  • Whether you need a specialty pharmacy
  • Current PA requirements and forms

Step 2: Gather Required Documentation

Your oncologist will need:

  • Diagnosis confirmation with appropriate ICD-10 codes
  • Pathology reports confirming Merkel cell carcinoma or urothelial carcinoma
  • Prior treatment history including chemotherapy regimens and outcomes
  • Imaging studies showing disease status
  • Treatment plan with dosing per FDA labeling

Step 3: Submit Through Carelon

Horizon Blue Cross Blue Shield uses Carelon Medical Benefits Management for oncology drug reviews. Your provider submits via:

  • Carelon provider portal
  • Fax (verify current number with Carelon)
  • Include HCPCS code J9023

Step 4: Track Decision Timeline

  • Standard PA: Decision within 10 calendar days
  • Expedited PA: Decision within 72 hours (for urgent cases)
  • Missing information: Additional 10 days after provider submits required documents
Tip: Request expedited review if you have progressive cancer or if treatment delays could cause harm. Document the urgency in your submission.

New Jersey Step Therapy Protections

Starting January 1, 2026, New Jersey's new step therapy law (Assembly Bill A1825) strengthens protections for patients on state-regulated plans. While this primarily affects state employee and Medicaid plans, the principles apply broadly.

Medical Exception Criteria

A step therapy exception must be granted if your prescribing provider documents that the required step therapy drug:

  1. Is contraindicated or likely to cause adverse harm
  2. Is expected to be ineffective based on clinical evidence
  3. Was previously tried and discontinued due to lack of efficacy or adverse events
  4. Is not in the patient's best medical interest
  5. Patient is stable on the prescribed drug for ≥180 days

Response Timeline Requirements

  • Urgent cases: 24 hours
  • Non-urgent cases: 72 hours

For current Blue Cross Blue Shield step therapy requirements, contact your plan directly as policies vary by specific Blue Cross Blue Shield affiliate.

Internal Appeals Process

If your initial PA is denied, New Jersey requires insurers to provide internal appeal rights with specific timelines.

Stage 1 Appeal (Reconsideration)

  • Deadline to file: 180 days from denial notice
  • Decision timeline: 10 calendar days (standard), 72 hours (expedited)
  • How to file: Via insurer's member portal, phone, fax, or mail

Stage 2 Appeal

  • Deadline to file: 180 days from Stage 1 denial
  • Decision timeline: 20 business days (standard), 72 hours (expedited)
  • Additional review: Often involves medical director review

Required Documentation for Appeals

Include with every appeal:

  • Original denial letter
  • Updated medical records
  • Physician letter addressing specific denial reasons
  • Any new clinical evidence (labs, imaging, treatment response)
Note: You must complete both internal appeal levels before proceeding to external review through IHCAP.

External Review Through IHCAP

New Jersey's Independent Health Care Appeals Program (IHCAP) provides external review after you've exhausted internal appeals.

Eligibility and Timeline

  • Who qualifies: Patients with fully insured plans (not self-funded ERISA plans)
  • Filing deadline: 4 months (180 days) from final internal denial
  • Review timeline: 45 calendar days (standard), 48 hours (expedited)

How to File with Maximus Federal Services

IHCAP is now operated by Maximus Federal Services. Submit your appeal:

Online: njihcap.maximus.com
Phone: 1-888-393-1062
Mail: NJ DOBI Office of Managed Care, Attn: IHCAP

Required Documents

  • Final denial letter from Blue Cross Blue Shield
  • Complete medical records
  • Detailed physician statement explaining medical necessity
  • Any supporting medical literature or guidelines

Success Factors

External appeals have approximately a 50% success rate nationwide. Strengthen your case by:

  • Including FDA approval letters for your specific indication
  • Providing detailed prior treatment history
  • Submitting peer-reviewed literature supporting off-label use (if applicable)
  • Requesting expedited review for urgent medical situations
From our advocates: "We've seen oncology appeals succeed when providers include detailed progression imaging and explain why alternative checkpoint inhibitors aren't suitable. The key is addressing the insurer's specific denial reason with clinical evidence."

Continuity of Care for Cancer Patients

New Jersey law provides special protections when your oncologist leaves your Blue Cross Blue Shield network during active cancer treatment.

Cancer Treatment Protections

Under N.J.A.C. 11:24-3.6, insurers must continue coverage for oncological treatment at contracted rates for up to one year after provider termination if medically necessary.

How to Request Continuity Coverage

  1. Act quickly: Submit request within 30 business days of termination notice
  2. Get physician certification: Your oncologist must document that continued treatment is medically necessary
  3. Submit to insurer: Use Horizon's Continuity of Care Coverage Agreement form

Coverage Duration by Condition

  • Cancer treatment: Up to 1 year
  • Post-operative care: Up to 6 months
  • General ongoing care: Up to 4 months

Common Denial Reasons and Solutions

Denial Reason How to Overturn Required Documentation
Not medically necessary Submit updated clinical notes showing disease progression or treatment failure Recent imaging, pathology, oncologist letter
Off-pathway use Provide NCCN guidelines or peer-reviewed studies supporting use Medical literature, specialist consultation
Missing prior therapy documentation Document all previous treatments and outcomes Treatment records, pharmacy records, physician notes
Site of care restriction Request exception for appropriate infusion setting Facility accreditation, medical necessity letter
Quantity/dosing limits Justify dosing per FDA label or clinical guidelines Body surface area calculation, dosing rationale

When to Escalate and Get Help

Contact New Jersey Regulators

If you're having persistent problems with Blue Cross Blue Shield, contact:

NJ Department of Banking and Insurance
Consumer Hotline: 1-800-446-7467
IHCAP Specific: 1-888-393-1062

Patient Advocacy Resources

  • Cancer Support Community: Free case management and appeals assistance
  • Patient Advocate Foundation: Co-pay assistance and insurance navigation
  • Counterforce Health: Automated appeals platform that helps turn insurance denials into targeted, evidence-backed appeals by analyzing denial letters and drafting point-by-point rebuttals aligned to your plan's specific rules

Consider consulting a healthcare attorney if:

  • Multiple external appeals have been denied
  • You suspect bad faith denial practices
  • Your case involves significant financial hardship

FAQ

How long does Blue Cross Blue Shield PA take in New Jersey?
Standard prior authorization decisions are made within 10 calendar days. Expedited requests for urgent cases are decided within 72 hours.

What if Bavencio is non-formulary on my plan?
You can request a formulary exception by documenting that formulary alternatives have failed or are contraindicated. Submit through your plan's exception process with supporting clinical documentation.

Can I request an expedited appeal?
Yes, if treatment delays would cause serious harm to your health. Request expedited review at every level and document the medical urgency.

Does step therapy apply if I failed treatments outside New Jersey?
Yes, prior treatment failures from other states count toward step therapy requirements. Provide complete medical records from all previous providers.

What's the difference between PA and formulary exception?
Prior authorization is required even for covered drugs to verify medical necessity. Formulary exceptions are needed when the drug isn't covered at all on your plan's drug list.

Can my doctor file appeals on my behalf?
Yes, New Jersey allows providers to file external appeals with patient consent. Your oncologist's office can handle most of the paperwork.

Are there cost assistance programs for Bavencio?
Check with Merck KGaA/Pfizer for manufacturer patient assistance programs. Some foundations also provide grants for cancer treatment copays.

What if I have a self-funded employer plan?
Self-funded ERISA plans follow federal rules instead of New Jersey state protections. Contact your plan administrator for specific appeal procedures.

Disclaimer: This information is for educational purposes only and is not medical or legal advice. Coverage decisions depend on your specific insurance plan and medical circumstances. Always consult with your healthcare provider and insurance plan for personalized guidance.

For complex appeals or challenging denials, Counterforce Health offers specialized support in turning insurance denials into successful appeals through evidence-based advocacy tailored to your specific payer's requirements.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.